Stay updated on Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.5.4, replacing the previous v3.5.3 to reflect a new version of the study record.
    Difference
    0.1%
    Check dated 2026-05-17T09:37:53.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page footer version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site/software update rather than a change to the clinical study information.
    Difference
    0.1%
    Check dated 2026-04-25T18:40:40.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Revision: v3.5.2 updated from v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-18T13:34:55.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    No substantive changes detected in the study record; the study details and eligibility criteria appear unchanged.
    Difference
    0.1%
    Check dated 2026-04-11T10:40:56.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Revision: v3.5.0 updated from the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T01:06:44.000Z thumbnail image
  9. Check
    91 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-06T18:40:03.000Z thumbnail image

Stay in the know with updates to Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial page.